Press "Enter" to skip to content

New patent for Novartis drug MAYZENT

0
Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug MAYZENT

Annual Drug Patent Expirations for MAYZENT
Annual Drug Patent Expirations for MAYZENT

Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has one hundred and twenty-five patent family members in thirty-nine countries.

The generic ingredient in MAYZENT is siponimod fumaric acid. One supplier is listed for this compound. Additional details are available on the siponimod fumaric acid profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug MAYZENT
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions